000			02040nam a22002417a 4500
003			ISI Library, Kolkata
005			20240903140617.0
008			240827b |||||||| |||| 00| 0 eng d
040			_aISI Library _bEnglish
082	0	4	_223rd _a100 SD:610.621 _bWHO.TR.693
110	1		_aWHO scientific grop on viral vaccines and antiviral drugs _eCorporate author
245	1	0	_aViral vaccines and antiviral drugs: _breport of a WHO scientific group/ _cWHO scientific group on viral vaccines and antiviral drugs
260			_aGeneva: _bWorld health organization, _c1983.
300			_a72 pages; _bdiagrams; _c19 cm.
490	0		_aTechnical Report Series; _v693
504			_aIncludes bibliography
505	0		_a1. Introduction -- 2. Antiviral immune responses -- 3. New approaches to vaccine development -- 4. Developments in interferons and antiviral compounds -- 5. Consideration of specific viral diseases -- 6. Recommendations
520			_aIn order that the new technologies are harnessed for the maximum benefit of all countries, it is essential that WHO should coordinate the efforts of scientists and others involved in research and development work in this field. Careful consideration should be given to clinical studies of new vaccines and drugs and to their standardization and control. During the past decade, communicable diseases have continued to have a considerable impact on morbidity and mortality, often resulting in an insupportable burden on national health resources. In many areas, viral infections account for a major proportion of the total incidence of communicable disease and, moreover, are often accompanied by secondary bacterial infections. In some countries, effective prevention and control of certain viral diseases, such as measles and poliomyelitis, is adequate using the vaccines currently available. Nevertheless, improvements in the prevention and control
650	0		_aBiological Science
650	0		_aVaccines and antiviral drugs
710	1		_aWorld health organization (WHO)
942			_2ddc _cRP
999			_c436014 _d436014